Richards Merrill & Peterson Inc. Buys 317 Shares of Danaher Corporation $DHR

Richards Merrill & Peterson Inc. increased its stake in Danaher Corporation (NYSE:DHR) by 11.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,210 shares of the conglomerate’s stock after purchasing an additional 317 shares during the period. Richards Merrill & Peterson Inc.’s holdings in Danaher were worth $634,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the company. GHP Investment Advisors Inc. raised its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 99 shares in the last quarter. Sierra Ocean LLC lifted its position in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new stake in Danaher during the first quarter valued at $31,000. Red Tortoise LLC grew its stake in Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the period. Finally, Costello Asset Management INC acquired a new position in shares of Danaher during the 1st quarter valued at $41,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $223.03 on Friday. The firm’s 50 day moving average is $202.73 and its 200 day moving average is $198.36. The stock has a market capitalization of $157.54 billion, a P/E ratio of 45.99, a PEG ratio of 3.41 and a beta of 0.77. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23. The company has a current ratio of 1.52, a quick ratio of 1.22 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the firm posted $1.71 EPS. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio is presently 26.39%.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the business’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Guggenheim reaffirmed a “buy” rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday. Redburn Partners set a $220.00 target price on Danaher in a research report on Wednesday, October 8th. JPMorgan Chase & Co. lifted their target price on Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research note on Wednesday. Finally, Rothschild & Co Redburn restated a “neutral” rating and set a $220.00 price objective (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $243.39.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.